Johnson & Johnson: raises EPS target range.
(CercleFinance.com) - After a better-than-expected Q2, Johnson & Johnson (J&J) has raised its FY adjusted EPS target range to between 7.
12 dollars and 7.22 dollars vs. 7 dollars to 7.15 dollars previously.
Over the past quarter, the health group posted adjusted net income of 5 billion dollars, meaning EPS that is up 5.2% at 1.83 dollar, while the consensus expected just under 1.80 dollar.
At 18.8 billion dollars, J&J's quarterly revenue increased 1.9%. In operating terms (excluding currency effects), revenues increased by 2.9%, including a 0.5% increase excluding changes in its consolidation scope.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
12 dollars and 7.22 dollars vs. 7 dollars to 7.15 dollars previously.
Over the past quarter, the health group posted adjusted net income of 5 billion dollars, meaning EPS that is up 5.2% at 1.83 dollar, while the consensus expected just under 1.80 dollar.
At 18.8 billion dollars, J&J's quarterly revenue increased 1.9%. In operating terms (excluding currency effects), revenues increased by 2.9%, including a 0.5% increase excluding changes in its consolidation scope.
Copyright (c) 2017 CercleFinance.com. All rights reserved.